New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
November 25, 2013
11:37 EDTABMD, HBAN, OREX, STSI, UNMHigh option volume stocks: HBAN UNM OREX ABMD STSI
News For HBAN;UNM;OREX;ABMD;STSI From The Last 14 Days
Check below for free stories on HBAN;UNM;OREX;ABMD;STSI the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
09:59 EDTHBANOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
05:31 EDTHBANHuntington Bancshares downgraded to Outperform from Strong Buy at Raymond James
Raymond James downgraded Huntington Bancshares to Outperform citing a lack of near-term catalysts. The firm lowered its price target for shares to $10.50 from $12.
April 16, 2014
10:23 EDTHBANHuntington says credit quality continues to show 'steady' improvement
Subscribe for More Information
09:38 EDTHBANHuntington Bancshares sees NII growing 'moderately'
Says committed to delivering positive operating leverage for FY14. Says residential mortgages, home equity and CRE are expected to grow modestly. Anticipate an increase in earning assets as total loans moderately grow and investment securities remain near current levels. Says FY NIM will experience continued downward pressure due to competitive loan pricing and growth in investment securities. Says excluding the impact of net MSR activity and securities gains, noninterest income is expected to be slightly higher than seasonally low 1Q14 levels. Noninterest expense is expected to be slightly higher than current levels, excluding significant items. Comments from slides that will be presented on the Q1 earnings conference call.
06:00 EDTHBANHuntington Bancshares reports Q1 EPS 17c, consensus 17c
Subscribe for More Information
April 15, 2014
15:19 EDTHBANNotable companies reporting before tomorrow's open
Subscribe for More Information
08:05 EDTABMDAbiomed acquires exclusive license for Opsens' optical sensor technology
Abiomed announced its acquisition of an exclusive license from collaboration partner Opsens. Through this exclusive licensing agreement, which covers the use of certain optical sensor technology in the field of cardio-circulatory assist devices, Opsens' miniature optical pressure sensors will be integrated into the Impella heart pump catheters to help further automate the control and operation of the Impella device in the catheterization lab. This licensing agreement, which secures Abiomed's rights to the technology and gives Abiomed the right to manufacture the sensors, is a continuation of an initial collaboration, entered into between Opsens and Abiomed in 2010.
April 10, 2014
07:34 EDTABMDAbiomed shares attractive following recent weakness, says Stephens
Stephens believes Abiomed shares are attractively valued following their recent weakness given the stock's valuation relative to peers. The firm says Abiomed remains one of its top ideas and reiterates its Overweight rating and $34 price target on the stock.
April 9, 2014
08:48 EDTHBANHuntington Bancshares to acquire 11 branches in central, east Michigan
Subscribe for More Information
April 8, 2014
11:03 EDTOREXPiper Jaffray's biopharm analyst holds an analyst/industry conference call
Biopharm Analyst Schimmer discusses PCSK9 Inhibitors and other atherosclerosis approaches on an Analyst/Industry conference call. Relevant companies AEGR, ALNY, AMGN, ARNA, AZN, BMY, CBST, LLY, ESPR, GSK, ICPT, ISIS, MNKD, MRK, OREX, PFE, REGN, RHHBY, SNY and VVUS may be included on the Analyst/Industry conference call to be held on April 10 at 3 pm.
08:07 EDTABMDAbiomed receives CE Mark for Impella RP
Abiomed announced it has received CE Marking approval in the European Union to market the Impella RP device, a new percutaneous Impella heart pump that provides temporary ventricular support for patients with right ventricular failure. The Impella RP is a percutaneous heart pump that is implanted through a single access site in the patient's leg and deployed through the venous system, across the right side of the heart without requiring a surgical procedure. The Impella RP is not currently cleared for sale or use in the United States.
April 7, 2014
09:34 EDTSTSIActive equity options trading on open
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the disclaimer & terms of use